These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 231062)

  • 1. Effects of somatostatin on insulin and glucagon in patients with insulinoma.
    Fallucca F; Mirabella C; Tamburrano G; Gambardella S; Aufieri G; Barbetti F; Andreani D
    J Endocrinol Invest; 1979; 2(3):257-60. PubMed ID: 231062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma glucagon in insulinoma.
    Ohneda A; Matsuda K; Horigome K; Ishii S; Yanbe A; Maruhama Y
    Acta Diabetol Lat; 1977; 14(5-6):219-28. PubMed ID: 207064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of somatostatin and somatostatin analogs in a patient with a glucagonoma.
    Kahn CR; Bhathena SJ; Recant L; Rivier J
    J Clin Endocrinol Metab; 1981 Sep; 53(3):543-9. PubMed ID: 6114963
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma insulin response to various secretagogues in insulinoma.
    Ohneda A; Kobayashi T; Nihei J
    Tohoku J Exp Med; 1982 Apr; 136(4):447-57. PubMed ID: 6285549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five cases of somatostatinoma: clinical heterogeneity and diagnostic usefulness of basal and tolbutamide-induced hypersomatostatinemia.
    Pipeleers D; Couturier E; Gepts W; Reynders J; Somers G
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1236-42. PubMed ID: 6132927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interrelationships among insulin, glucagon, and gastric inhibitory polypeptide in insulinoma.
    Nelson RL; Service FJ; Go VL
    Mayo Clin Proc; 1980 Mar; 55(3):138-45. PubMed ID: 6243728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma insulin studies in the diagnosis of insulinoma.
    McKiddie MT; Buchanan KD; Abernethy RJ
    Scott Med J; 1969 Jun; 14(6):200-8. PubMed ID: 4307323
    [No Abstract]   [Full Text] [Related]  

  • 8. Secretory response and immunochemical heterogeneity of glucagon in plasma and tumor extracts of a patient with glucagonoma.
    Torre L; Vazquez JA; Blázquez E
    Horm Res; 1986; 23(3):159-66. PubMed ID: 3005153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Behavior of plasma glucagon in experimental fasting and somatostatin test in islet cell tumors].
    Drost H; Berger M; Berchtold P; Wiegelmann W; Zimmermann H; Gries FA
    Med Welt; 1976 Jul; 27(28):1381-3. PubMed ID: 183080
    [No Abstract]   [Full Text] [Related]  

  • 10. Responses of patients with insulinomas to stimulators and inhibitors of insulin release that have been linked with cyclic adenosine monophosphate.
    Lins PE; Efendić S
    Diabetes; 1979 Mar; 28(3):190-5. PubMed ID: 221293
    [No Abstract]   [Full Text] [Related]  

  • 11. The glucagonoma syndrome: stimulus-induced plasma responses of circulating glucagon components IRG9000 and IRG3500.
    Hendriks T; Jansen JB; van Tongeren JH
    Acta Endocrinol (Copenh); 1984 Feb; 105(2):226-32. PubMed ID: 6141691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant somatostatinoma: clinical features and metabolic studies.
    Axelrod L; Bush MA; Hirsch HJ; Loo SW
    J Clin Endocrinol Metab; 1981 May; 52(5):886-96. PubMed ID: 6112232
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pancreatic function tests].
    Abe M; Ikeda Y; Yaginuma M; Shimizu N
    Nihon Rinsho; 1969 Feb; 27(2):291-300. PubMed ID: 4306418
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter: Somatostatin and insulinoma.
    Christensen SE; Hansen AP; Lundbaek K; Orskov H; Seyer-Hansen K
    Lancet; 1975 Jun; 1(7922):1426. PubMed ID: 49589
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnostic value of intravenous glucagon test in insulinoma.
    Oneda A; Maruhama Y; Itabashi H; Horigome K; Yanbe A
    Tohoku J Exp Med; 1975 Jul; 116(3):205-11. PubMed ID: 170711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tolbutamide plus somatostatin test in the diagnosis of insulinomas].
    Jara Albarrán A; Caballero Asensi A; García Peris P; Coste A; Toledano E; Gorospe C; Caviola E; Palacios Mateos JM
    Rev Clin Esp; 1982 Jan; 164(2):105-9. PubMed ID: 6124027
    [No Abstract]   [Full Text] [Related]  

  • 17. [A case of insulinoma].
    Deliège M; Jardon-Jeghers C
    Acta Clin Belg; 1980; 35(5):306-13. PubMed ID: 6261504
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypoglycemia: tolbutamide and leucine tests in insulinoma.
    Frawley TF; Pensuwan S
    Med Clin North Am; 1968 Mar; 52(2):283-94. PubMed ID: 4297807
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of somatostatin in the Syrian hamster bearing a transplantable islet-cell tumor.
    Luyckx AS; Lefebvre PJ
    Horm Metab Res; 1978 Mar; 10(2):105-10. PubMed ID: 206496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of hypoglycemia in insulinoma patients: suppression of hepatic glucose production by insulin.
    Rizza RA; Haymond MW; Verdonk CA; Mandarino LJ; Miles JM; Service FJ; Gerich JE
    Diabetes; 1981 May; 30(5):377-81. PubMed ID: 6262168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.